MannKind Corporation (MNKD) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Mannkind Corporation.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.976 -- 00:00:06.144 Good morning and welcome to the Mankind Corporation 3rd Quarter 2025 00:00:06.144 -- 00:00:09.290 Financial Results Earnings Call. 00:00:09.290 -- 00:00:14.518 As a reminder, this call is being recorded on November 5th 2025 00:00:14.518 -- 00:00:19.246 and will be available for playback on the Mankind Corporation website shortly after the 00:00:19.246 -- 00:00:24.128 conclusion of this call and available for approximately 90 days. 00:00:24.128 -- 00:00:27.412 This call will contain forward-looking statements. 00:00:27.412 -- 00:00:31.918 Such forward-looking statements are subject to risks and uncertainties that may cause 00:00:31.918 -- 00:00:36.321 actual results to differ materially from these expectations. 00:00:36.604 -- 00:00:41.690 For further information on the company's risk factors, please see the form 10Q 00:00:41.690 -- 00:00:45.853 for the quarterly period ended September 30th, 2025, 00:00:46.256 -- 00:00:51.044 the earnings release, and the slides prepared for this presentation. 00:00:51.044 -- 00:00:56.210 Joining us today for Mankind are Chief Executive Officer Michael Castagna 00:00:56.210 -- 00:00:59.754 and Chief Financial Officer Chris Prentice. 00:00:59.754 -- 00:01:02.157 I'd now like to turn the conference over to Mr. 00:01:02.157 -- 00:01:05.821 Castagna. Please go ahead, sir. 00:01:05.821 -- 00:01:10.407 Good morning and thank you for joining our Q3 2025 earnings call. 00:01:10.407 -- 00:01:15.132 Let me start with the Q3 highlights. We delivered a record revenue of a quarter of $82 00:01:15.132 -- 00:01:16.574 million. 00:01:16.574 -- 00:01:21.402 We also strengthened our portfolio with the acquisition of SC Pharmaceuticals. 00:01:21.402 -- 00:01:26.508 On the pipeline side, Afrez's supplemental BLA was ac...